ARCHIVES

NCI Would Fund 1,052 Competing Grants In Fy95

This article is from The Cancer Letter archive.

Vol. 20 No. 06 | February 11, 1994

Download PDF Visit The Full Archive

Related Articles

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009

PET Response Can Predict Increased Survival In Patients

April 27, 2012

VP Bush Visits NIH To Learn About AIDS

April 17, 1987

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009

Payline Not Set For CCOPs Yet In Recompetition

March 1, 1991

NCI Finds Physician Recommendation Drives Patient Demand For ABMT

July 19, 1996